title: Transdermal peptide delivery using electroporation.
authors.affiliation: Cygnus, Inc., Redwood City, California 94063, USA.
authors.forename: R O
authors.initials: RO
authors.lastname: Potts
authors.forename: D
authors.initials: D
authors.lastname: Bommannan
authors.forename: O
authors.initials: O
authors.lastname: Wong
authors.forename: J A
authors.initials: JA
authors.lastname: Tamada
authors.forename: J E
authors.initials: JE
authors.lastname: Riviere
authors.forename: N A
authors.initials: NA
authors.lastname: Monteiro-Riviere
mesh_terms: D000279:Administration, Cutaneous; D000818:Animals; D001692:Biological Transport; D002116:Calcitonin / Q000008:administration & dosage; D018274:Electroporation / Q000009:adverse effects; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage; D007328:Insulin / Q000008:administration & dosage; D008051:Lipid Bilayers / Q000737:chemistry; D009496:Neurotensin / Q000008:administration & dosage; D010455:Peptides / Q000008:administration & dosage*; D012867:Skin / Q000378:metabolism; D013552:Swine; D014667:Vasopressins / Q000008:administration & dosage
chemical_list: D007328:Insulin; D008051:Lipid Bilayers; D010455:Peptides; D014667:Vasopressins; D007987:Gonadotropin-Releasing Hormone; D009496:Neurotensin; D002116:Calcitonin